Navigation Links
Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2008 Results and Announces Share Repurchase
Date:11/6/2008

NANJING, China, Nov. 6 /Xinhua-PRNewswire/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company') (NYSE: SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti- cancer biotech product Endu in China, today reported unaudited financial results for the quarter ended September 30, 2008 and announced that its Board of Directors has approved a share repurchase program.

Highlights

-- Total revenue increased to RMB443.4 million (US$65.3 million) for the

third quarter, representing a 37.1% year-over-year growth;

-- Net income was RMB91.2 million (US$13.4 million) for the third quarter,

representing a 24.7% year-over-year growth;

-- Gross margin was 78.3% for the third quarter, which was impacted by a

one-off contract sale transaction involving the resale of generic drugs

for other pharmaceutical companies, which is now ceased; and

-- The board of directors has approved a share repurchase program under

which Simcere Pharmaceutical Group may purchase up to US$50 million

worth of its issued and outstanding American depositary shares

("ADSs") in the following twelve months.

Mr. Jinsheng Ren, Chairman and CEO of Simcere Pharmaceutical Group, commented: "We are pleased to report solid year on year growth for the third quarter. We are encouraged by the continued growth of our edaravone products, although our Endu sales continued to be affected by the sales team restructuring and an expanded program to supply Endu free of charge in clinical studies. Our other branded generic products grew steadily this quarter. In October, we successfully launched Anxin, our first-to-market biapenem
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday, November 5, 2007
2. Simcere Pharmaceutical Group Announces the Appointment of New Vice President of Marketing and Two Senior Promotions
3. Simcere Pharmaceutical Group Reports Proposed Private Sale of Ordinary Shares by Existing Shareholder
4. Simcere Pharmaceutical Group to Participate in Credit Suisse 3rd Annual Healthcare Trip
5. Simcere Pharmaceutical Group to Participate in Upcoming Investor Conferences in New York
6. Simcere Pharmaceutical Group to Announce Second Quarter 2008 Earnings on Tuesday, August 5, 2008
7. Simcere Pharmaceutical Group Announces Two Senior Promotions and Appointment of New Vice President of Human Resources
8. Simcere Pharmaceutical Group to Announce Third Quarter 2008 Earnings on Thursday, November 6, 2008
9. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
10. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
11. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 23, 2014 This is a ... of the Phenolic Resin industry in Global and ... industry, including definitions, applications and industry chain structure. ... are provided with a focus on history, developments, ... comparison between the international and Chinese situation is ...
(Date:9/23/2014)... ATCC, the premier global biological materials resource ... appointments to the senior leadership team. Barbie Bigelow has ... Technology and Dr. Maryellen de Mars also joins as ... roles are new positions at ATCC. ... ATCC described the additions as part of a revitalization ...
(Date:9/23/2014)... Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced three ... to $5 million. The orders are all odour control projects ... continue to see new orders coming in," said Peter ... has climbed to over $11 million." About ... company that designs, manufactures and distributes a comprehensive line of ...
(Date:9/23/2014)... This is a professional and in-depth ... (IPA) industry. The report provides a basic overview ... chain structure. Global market analysis and Chinese domestic ... history, developments, trends and competitive landscape of the ... situation is also offered. , The report ...
Breaking Biology Technology:Phenolic Resin Industry (International, China) Development Policy and Plan Now Available at ReportsnReports.com 2ATCC Announces New Appointments to its Leadership Team 2ATCC Announces New Appointments to its Leadership Team 3(IPA) Isopropanol Industry International & China Development Trend Analysis Now Available at DeepResearchReports.com 2(IPA) Isopropanol Industry International & China Development Trend Analysis Now Available at DeepResearchReports.com 3
... ... its first relaunch, and came out as a beta. In this relaunch they have focused on ... get more relevant results. They have tried to get the users to get and give a ... , ...
... POMPEY, France, September 17 Novasep is ... - France, specialized in the development,and manufacturing of ... "Potent Compound Safety Certification" from SafeBridge(R),Consultants, Inc. , ... Safety Certification program verifies,Novasep,s performance in the management, ...
... SCOTTSDALE, Ariz., Sept. 17 MedTrust Online, a ... options for challenging patient cancer cases, has surpassed 5,000 ... Online also announced today that world-renowned oncologist Dr. Henry ... advisors. , , "5,000 users is ...
Cached Biology Technology:ePDF is Happy to Announce that ePDF has Completed its First Relaunch, and has Come Out as a Beta 2Novasep Gains SafeBridge(R) "Potent Compound Safety Certification" for its Le Mans Facility 2Novasep Gains SafeBridge(R) "Potent Compound Safety Certification" for its Le Mans Facility 3MedTrust Online Surpasses 5,000 Registered Users and Adds Dr. Henry Friedman to Oncology Advisory Board 2
(Date:9/23/2014)... moving body relies on an orchestrated response of bones, joints, ... literally the geometry of a critical part like ... just a footfall error at the root of one of ... cruciate ligament tear. In fact, size of the femoral ... and volume of the ACL combine to influence the ...
(Date:9/23/2014)... MADISON, Wis. A multidisciplinary team at the University ... creating a faster, more affordable way to screen for ... development. , The National Institutes of Health (NIH) announced ... 11 universities receiving support to continue the promising work ... program. The team will receive approximately $7 million over ...
(Date:9/23/2014)... Health will award funds to support the next phase ... improve ways of predicting drug safety and effectiveness. Researchers ... human tissue chips and combine them into an integrated ... human body. Led by the National Center for Advancing ... at $17 million in 2014 with additional support over ...
Breaking Biology News(10 mins):Does size matter? MRI imaging sheds light on athletes most at risk for severe knee injury 2Does size matter? MRI imaging sheds light on athletes most at risk for severe knee injury 3UW-Madison team developing 'tissue chip' to screen neurological toxins 2UW-Madison team developing 'tissue chip' to screen neurological toxins 3NIH funds next phase of Tissue Chip for Drug Screening program 2NIH funds next phase of Tissue Chip for Drug Screening program 3NIH funds next phase of Tissue Chip for Drug Screening program 4
... Leading scientists, physicians, and veterinarians are uncovering new links ... implications for human health. , "Marine mammals are providing ... says Paul Sandifer, Chief Scientist for the new Oceans ... and Atmospheric Administration (NOAA). "There is mounting evidence ...
... there's a constant shuffling of genetic material going ... via ocean-dwelling viruses, scientists report this week in ... Sallie Chisholm and her colleagues at the Massachusetts ... new facet of evolution and helping scientists see ...
... gene responsible for making embryos male and forming the ... by Parkinson's disease. Published in the Feb. 21 ... why more men than women develop the degenerative disorder, ... 1.5 times more likely to develop Parkinson's disease than ...
Cached Biology News:Marine mammals are on the frontline of failing ocean health 2Marine mammals are on the frontline of failing ocean health 3Marine mammals are on the frontline of failing ocean health 4Marine mammals are on the frontline of failing ocean health 5Marine mammals are on the frontline of failing ocean health 6Scientists discover interplay between genes and viruses in tiny ocean plankton 2UCLA scientists find male gene in brain area targeted by Parkinson's 2
... bottoms,• Nonreversible lids with ... contamination,• Individual alphanumerical codes ... footprint for ease in ... cell attachment,• Sterilized by ...
... is a G1 cyclin required for G1-phase ... a proto-oncogene. cyclin D2 can phosphorylate ... Species Reactivity: Human, Mouse, and Rat. ... is particularly well suited for neutralization of ...
... combines shaking and rocking for maximal fluid movement. ... mm stainless steel or acrylic platform, it is ... operation. The platform angle is easily adjusted from ... action and rotation speed of platform is adjusted ...
... PROTEAN II xi 2-D system runs both gel dimensions ... tube gels can be separated in a single run ... cooling core in much the same manner as the ... the second-dimension slab gels may be cast in the ...
Biology Products: